Clinical Trials
11 trialsNCT07429266 2026-06-05
INTREPID
Ono Pharmaceutical Co., Ltd.
Phase 3 Recruiting
NCT05143957 2026-06-01
A Study to Evaluate Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx) in Patients With Polycythemia Vera
Ionis Pharmaceuticals, Inc.
Phase 2 Active not recruiting
NCT07441694 2026-05-29
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Incyte Corporation
Phase 1 Recruiting
NCT07469891 2026-05-29
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
Prelude Therapeutics
Phase 1 Recruiting
NCT06985147 2026-05-28
A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)
Disc Medicine, Inc
Phase 2 Recruiting
NCT02386800 2026-05-27
CINC424A2X01B Rollover Protocol
Novartis
Phase 4 Active not recruiting
NCT05558696 2026-05-07
IMG-7289-CTP-203
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
Phase 2 Completed
NCT05853458 2026-04-30
HU-F-AIM
Novartis
Phase 4 Terminated
NCT07529951 2026-04-14
Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers
Eilean Therapeutics
Phase 1 Not yet recruiting
NCT06351631 2026-04-02
MK-3543-017
Merck Sharp & Dohme LLC
Phase 3 Recruiting
NCT06093672 2026-03-25
GIV-IN-PV
Italfarmaco
Phase 3 Recruiting